MedPath

Evaluation of neoadjuvant chemotherapy for breast cancer using contrast-enhanced ultrasound (CE-US) imaging

Not Applicable
Conditions
breast cancer
Registration Number
JPRN-UMIN000022304
Lead Sponsor
Diagnosis Radiology of Tohoku University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

Exclusion criteria is 1.Patients who are pregnant or breast-feeding. 2.Patients who have allergy to Sonazoid. 3.Patients who have allergy to egg. 4.Patients who have pulmonary arteriovenous shunt or right-to-left shunt. 5.Patients who have severe heart or lung disease. 6.Patients to whom contrast-enhanced CT or MRI can not be performed due to renal failure. 7.Patients who have mental disease.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath